Balyasny Asset Management’s Immunogen Inc IMGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,496,758
| Closed | -$44.4M | – | 2545 |
|
|
2023
Q4 | $44.4M | Buy |
1,496,758
+1,484,838
| +12,457% | +$44M | 0.08% | 221 |
|
|
2023
Q3 | $189K | Sell |
11,920
-1,020,659
| -99% | -$16.2M | ﹤0.01% | 1562 |
|
|
2023
Q2 | $19.5M | Buy |
1,032,579
+929,828
| +905% | +$17.5M | 0.04% | 444 |
|
|
2023
Q1 | $395K | Sell |
102,751
-284,043
| -73% | -$1.09M | ﹤0.01% | 1597 |
|
|
2022
Q4 | $1.92M | Buy |
+386,794
| New | +$1.92M | 0.01% | 1086 |
|
|
2022
Q3 | – | Sell |
-109,741
| Closed | -$493K | – | 2850 |
|
|
2022
Q2 | $493K | Buy |
+109,741
| New | +$493K | ﹤0.01% | 1579 |
|
|
2021
Q3 | – | Sell |
-191,876
| Closed | -$1.26M | – | 2185 |
|
|
2021
Q2 | $1.26M | Buy |
+191,876
| New | +$1.26M | 0.01% | 1042 |
|
|
2019
Q2 | – | Sell |
-430,328
| Closed | -$1.17M | – | 1614 |
|
|
2019
Q1 | $1.17M | Buy |
430,328
+177,243
| +70% | +$480K | 0.01% | 876 |
|
|
2018
Q4 | $1.22M | Buy |
+253,085
| New | +$1.22M | 0.01% | 754 |
|
|
2018
Q2 | – | Sell |
-68,023
| Closed | -$716K | – | 1995 |
|
|
2018
Q1 | $716K | Buy |
68,023
+43,045
| +172% | +$453K | ﹤0.01% | 1150 |
|
|
2017
Q4 | $160K | Buy |
+24,978
| New | +$160K | ﹤0.01% | 1692 |
|
|
2016
Q3 | – | Sell |
-22,222
| Closed | -$68K | – | 1172 |
|
|
2016
Q2 | $68K | Buy |
+22,222
| New | +$68K | ﹤0.01% | 937 |
|